Using AI to build your medical product in Europe and the UK: Discuss with Taylor Wessing

​Join Taylor Wessing’s visiting life sciences device & IP lead partners from the UK and Germany for an in-depth exploration of the application of AI across the medical product development lifecycle in the UK and Europe.

​This session will feature expert case studies on the integration of AI at key stages including drug discovery, non-clinical development, clinical trials, manufacturing and post-authorisation. We’ll unpack the issues and opportunities that may arise from the use of AI at each of these stages, where the new EU AI Act may impact decision making and how to build product roadmaps accordingly.